An Assessment of the Effectiveness (Efficacy) of Odeston (Odeston®) in Patients With Chronic Cholecystitis in Real Medical Practice

ConditionChronic Cholecystitis

Trial statusNot yet recruiting

Trial phaseNot listed

Trial typeObservational

Biological sexAll

Age18-65

SponsorKazakhstan Scientific Society for Study of intestine diseases

About this trial

Post-marketing Observational Clinical Study: Assessment of the Effectiveness (Efficacy) of Odeston (Odeston®) in Patients With Chronic Cholecystitis in Real Medical Practice

Eligibility criteria

Qualifiers

Men and women aged 18 to 65 years;

BMI 18.5 - 40;

Verified diagnosis: chronic acalculous cholecystitis;

Voluntary desire to provide informed consent to participate in the study

Disqualifiers

Presence of stones in the gall bladder and bile ducts;

The presence of jaundice, cholestatic liver diseases, liver cirrhosis with decompensation;

Increased ALT, AST above the 3 upper limits of normal;

Hypersensitivity to the components of the drug Odeston;

Trial design

Treatments tested in this trial

Not listed

Trial groups

No trial groups listed

Locations15

Select a site below to view it on the map.

Sponsors and collaborators

Kazakhstan Scientific Society for Study of intestine diseases

Lead sponsor

Source ClinicalTrials.gov